Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)
ASSURE: An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
Sponsor: Gilead Sciences
This PHASE3 trial investigates Primary Biliary Cirrhosis and is currently ongoing. Gilead Sciences leads this study, which shows 51 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
51 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting PHASE3
-
Sep 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE3
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Apr 2025 — May 2025 [monthly]
Active Not Recruiting PHASE3
-
Mar 2025 — Apr 2025 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
▶ Show 46 earlier versions
-
Dec 2024 — Mar 2025 [monthly]
Recruiting PHASE3
-
Nov 2024 — Dec 2024 [monthly]
Recruiting PHASE3
-
Oct 2024 — Nov 2024 [monthly]
Recruiting PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Sep 2023 — Mar 2024 [monthly]
Recruiting PHASE3
-
Jul 2023 — Sep 2023 [monthly]
Recruiting PHASE3
-
May 2023 — Jul 2023 [monthly]
Recruiting PHASE3
-
Apr 2023 — May 2023 [monthly]
Recruiting PHASE3
-
Mar 2023 — Apr 2023 [monthly]
Recruiting PHASE3
-
Feb 2023 — Mar 2023 [monthly]
Recruiting PHASE3
-
Jan 2023 — Feb 2023 [monthly]
Recruiting PHASE3
-
Nov 2022 — Jan 2023 [monthly]
Recruiting PHASE3
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE3
-
Jun 2022 — Jul 2022 [monthly]
Recruiting PHASE3
-
Apr 2022 — Jun 2022 [monthly]
Recruiting PHASE3
-
Mar 2022 — Apr 2022 [monthly]
Recruiting PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE3
-
Jan 2022 — Feb 2022 [monthly]
Recruiting PHASE3
-
Dec 2021 — Jan 2022 [monthly]
Recruiting PHASE3
-
Nov 2021 — Dec 2021 [monthly]
Recruiting PHASE3
-
Oct 2021 — Nov 2021 [monthly]
Recruiting PHASE3
-
Sep 2021 — Oct 2021 [monthly]
Recruiting PHASE3
-
Jun 2021 — Sep 2021 [monthly]
Recruiting PHASE3
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE3
Status: Active Not Recruiting → Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE3
Status: Suspended → Active Not Recruiting · Phase: PHASE2_PHASE3 → PHASE3
-
Jan 2020 — Nov 2020 [monthly]
Suspended PHASE2_PHASE3
Status: Recruiting → Suspended
-
Nov 2019 — Jan 2020 [monthly]
Recruiting PHASE2_PHASE3
-
May 2019 — Nov 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2019 — Apr 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Nov 2018 — Jan 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Aug 2018 — Oct 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE2_PHASE3
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2018 — May 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2018 — Apr 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Dec 2017 — Feb 2018 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Gilead Sciences
For direct contact, visit the study record on ClinicalTrials.gov .